Similarly, antibody-mediated neutralization of HMGB1 has been shown to attenuate glial cell activation and prevent neuron loss in models of both Alzheimer’s disease and Parkinson’s disease (21, 48). This evidence concerns the gene HMGB1 and early-onset autosomal dominant Alzheimer disease.